Professor Peter Schmid

Professor Peter Schmid



25 years of experience
17 years as a specialist

Overall Rating

Overall Experience


Bedside Manner




Top feedback

“he is amazing. Kind, human and super intelligent. “
Read more


  • Medical Oncology
Show more

Languages spoken

  • English
Show more

Registered with

  • General Medical Council: 6111181
Show more

    Practices worked at

    London Bridge Hospital

    27 Tooley Street, London, United Kingdom, SE1 2PR
    2,540 reviews

    The Wellington Hospital

    St Johns Wood, London, United Kingdom, NW8 7JA
    1,440 reviews

    Specialist's working hours

    09:00 - 19:00
    13:00 - 19:00
    Not available
    09:00 - 12:00
    Not available
    Not available
    Not available


    Professor Schmid is an internationally renowned breast cancer oncologist. He is the clinical director of the Breast Cancer Centre at St. Bartholomew’s Hospital in London, and Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University London.

    Professor Peter Schmid’s work is devoted to incorporating novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer. He has an interest in breast cancer from diagnosis throughout treatment to optimal recovery, and also has a particular interest in triple-negative breast cancer, young women with breast cancer, pregnancy-associated breast cancer, and fertility-related issues. Professor Schmid is committed to patient-centered, holistic care, tailoring treatments for individual patients using biology, personal preference, and constant review of outcomes of care. He works in the context of a multidisciplinary team with breast care nurse support for patients. Professor Schmid has a strong interest in patient-doctor communication and ran a training program for oncologists and oncology nurses for many years. Professor Schmid’s research is dedicated to improving the care of women with breast cancer by developing more effective and less toxic treatments.

    It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.


    • Chemotherapy
    • Clinical Trials
    • Genetic Testing
    • Hormone Therapy
    • Immunotherapy
    • Neoadjuvant
    • Targeted Therapy
    • Video Consultation
    Read more

    Special interests

    • Breast Cancer
    Read more


    • Medical School (State Examination Medicine). 1997, Technical University of Munich (TUM), Germany. 
    • MD, Clinical Chemistry. 1998, Technical University of Munich (TUM), Germany. 
    • PhD, Medical Oncology. 2005, Charité University, Berlin, Germany.
    • FRCP. 2012, Royal College of Physicians
    Read more


    Powered by Doctify
    Promoting trust & transparency in healthcare